Abstract
Most genome-wide association studies have been of European individuals, even though most genetic variation in humans is seen only in non-European samples. To search for novel loci associated with blood lipid levels and clarify the mechanism of action at previously identified lipid loci, we used an exome array to examine protein-coding genetic variants in 47,532 East Asian individuals. We identified 255 variants at 41 loci that reached chip-wide significance, including 3 novel loci and 14 East Asian–specific coding variant associations. After a meta-analysis including >300,000 European samples, we identified an additional nine novel loci. Sixteen genes were identified by protein-altering variants in both East Asians and Europeans, and thus are likely to be functional genes. Our data demonstrate that most of the low-frequency or rare coding variants associated with lipids are population specific, and that examining genomic data across diverse ancestries may facilitate the identification of functional genes at associated loci.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Teslovich, T.M. et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707–713 (2010).
Willer, C.J. et al. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 45, 1274–1283 (2013).
Surakka, I. et al. The impact of low-frequency and rare variants on lipid levels. Nat. Genet. 47, 589–597 (2015).
Asselbergs, F.W. et al. Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am. J. Hum. Genet. 91, 823–838 (2012).
Kim, Y.J. et al. Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits. Nat. Genet. 43, 990–995 (2011).
Wu, Y. et al. Trans-ethnic fine-mapping of lipid loci identifies population-specific signals and allelic heterogeneity that increases the trait variance explained. PLoS Genet. 9, e1003379 (2013).
Lambert, N.G. et al. Risk factors and biomarkers of age-related macular degeneration. Prog. Retin. Eye Res. 54, 64–102 (2016).
Herder, C., Kowall, B., Tabak, A.G. & Rathmann, W. The potential of novel biomarkers to improve risk prediction of type 2 diabetes. Diabetologia 57, 16–29 (2014).
Wierzbicki, A.S. & Oben, J. Nonalcoholic fatty liver disease and lipids. Curr. Opin. Lipidol. 23, 345–352 (2012).
Kathiresan, S. A PCSK9 missense variant associated with a reduced risk of early-onset myocardial infarction. N. Engl. J. Med. 358, 2299–2300 (2008).
Tang, C.S. et al. Exome-wide association analysis reveals novel coding sequence variants associated with lipid traits in Chinese. Nat. Commun. 6, 10206 (2015).
Peloso, G.M. et al. Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks. Am. J. Hum. Genet. 94, 223–232 (2014).
Lange, L.A. et al. Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol. Am. J. Hum. Genet. 94, 233–245 (2014).
Liu, D.J. et al. Exome-wide association study of plasma lipids in >300,000 individuals. Nat. Genet. http://dx.doi.org/10.1038/ng.3977 (2017).
Holmen, O.L. et al. Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk. Nat. Genet. 46, 345–351 (2014).
Nejentsev, S., Walker, N., Riches, D., Egholm, M. & Todd, J.A. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324, 387–389 (2009).
Sanna, S. et al. Fine mapping of five loci associated with low-density lipoprotein cholesterol detects variants that double the explained heritability. PLoS Genet. 7, e1002198 (2011).
Nikpay, M. et al. A comprehensive 1,000 Genomes–based genome-wide association meta-analysis of coronary artery disease. Nat. Genet. 47, 1121–1130 (2015).
Krokstad, S. et al. Cohort profile: the HUNT Study, Norway. Int. J. Epidemiol. 42, 968–977 (2013).
Lu, X. et al. Genetic susceptibility to lipid levels and lipid change over time and risk of incident hyperlipidemia in Chinese populations. Circ. Cardiovasc. Genet. 9, 37–44 (2016).
Williams, G.S., Boyman, L. & Lederer, W.J. Mitochondrial calcium and the regulation of metabolism in the heart. J. Mol. Cell. Cardiol. 78, 35–45 (2015).
Parkner, T. et al. Soluble CD163: a biomarker linking macrophages and insulin resistance. Diabetologia 55, 1856–1862 (2012).
Carlsson, L.M. et al. ALK7 expression is specific for adipose tissue, reduced in obesity and correlates to factors implicated in metabolic disease. Biochem. Biophys. Res. Commun. 382, 309–314 (2009).
Johansson, A. et al. Linkage and genome-wide association analysis of obesity-related phenotypes: association of weight with the MGAT1 gene. Obesity (Silver Spring) 18, 803–808 (2010).
Spracklen, C.N. et al. Association analyses of East Asian individuals and transancestry analyses with European individuals reveal new loci associated with cholesterol and triglyceride levels. Hum. Mol. Genet. 26, 1770–1784 (2017).
Lee, D. et al. A method to predict the impact of regulatory variants from DNA sequence. Nat. Genet. 47, 955–961 (2015).
Do, R. et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat. Genet. 45, 1345–1352 (2013).
Rosenson, R.S., Davidson, M.H., Hirsh, B.J., Kathiresan, S. & Gaudet, D. Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease. J. Am. Coll. Cardiol. 64, 2525–2540 (2014).
Helgadottir, A. et al. Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease. Nat. Genet. 48, 634–639 (2016).
Voight, B.F. et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 380, 572–580 (2012).
Zhang, Y. et al. Rare coding variants and breast cancer risk: evaluation of susceptibility loci identified in genome-wide association studies. Cancer Epidemiol. Biomarkers Prev. 23, 622–628 (2014).
Goldstein, J.I. et al. zCall: a rare variant caller for array-based genotyping: genetics and population analysis. Bioinformatics 28, 2543–2545 (2012).
Liu, D.J. et al. Meta-analysis of gene-level tests for rare variant association. Nat. Genet. 46, 200–204 (2014).
Feng, S., Liu, D., Zhan, X., Wing, M.K. & Abecasis, G.R. RAREMETAL: fast and powerful meta-analysis for rare variants. Bioinformatics 30, 2828–2829 (2014).
Lu, X. et al. Coding-sequence variants are associated with blood lipid levels in 14,473 Chinese. Hum. Mol. Genet. 25, 4107–4116 (2016).
Lu, X. et al. Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease. Nat. Genet. 44, 890–894 (2012).
Willer, C.J., Li, Y. & Abecasis, G.R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010).
GenSalt Collaborative Research Group. GenSalt: rationale, design, methods and baseline characteristics of study participants. J. Hum. Hypertens. 21, 639–646 (2007).
Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).
Thurman, R.E. et al. The accessible chromatin landscape of the human genome. Nature 489, 75–82 (2012).
Acknowledgements
We thank all the participants of this study for their contributions. X. Lu is supported by the CAMS Innovation Fund for Medical Sciences (grants 2016-I2M-1-009, 2017-I2M-1-004, and 2016-I2M-1-011) and the National Science Foundation of China (grants 81422043, 91439202, 81370002, 81773537, and 81230069). C.J.W. is supported by the National Institutes of Health (grant HL135824). S.K. and C.J.W. are supported by the National Institutes of Health (grant HL127564). P.C.S. was supported by the Hong Kong Research Grants Council (grants TRS T12/705/11 and GRF 17128515). G.M.P. is supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (award K01HL125751). We thank P. Marshall for professional editing. Additional acknowledgments of funding sources for the primary studies are provided in Supplementary Note 1.
Author information
Authors and Affiliations
Consortia
Contributions
X. Lu, C.J.W., G.M.P., D.J.L., D.G., and K.L.M. drafted the manuscript. C.J.W., D.G., X. Lu, P.C.S., S.K., K.L.M., and Y.E.C. coordinated the project. X. Lu, D.J.L., G.M.P., and H.Z. served as the central meta-analysis group. X. Lu and J.B.N. carried out eQTL analysis. X. Lu and W. Zhou carried out DeltaSVM analysis. X. Lu, G.M.P., D.J.L., Y. Wu, H.Z., J. Li, C.S.T., R.D., J. Long, X.G., C.N.S., Y.C., Y. Wang, C.Y.Y.C, Q.F., J.S., X.Y., W. Zhao, M.H., and J.B.N. carried out cohort data analysis. W. Zhou, H.L., C.C.K., J. Liu, L.W., F.W., J.S., and W.H. carried out cohort genotyping. H.L., M.X., X. Liu, Y.Z., L.S., Y.G., Y. Hu, K.Y., J.H., Q.C., S.C., A.B.F., L.S.A., P.G.-L., S.D., K.H., and L.G.F. carried out cohort phenotyping. X. Lu, W.H.-H.S., S.S.C., A.B.F., L.S.A., P.G.-L., S.D., R.V., Y.-D.I.C., X.-O.S., K.S.L.L., T.Y.W., S.K.G., Z.M., K.H., L.G.F., H.T., Y. Huo, C.Y.C., Y.E.C., W. Zheng, E.S.T., W.G., X. Lin, W.H., G.A., S.K., K.L.M., T.W., P.C.S., D.G., and C.J.W. were the principal investigators for the cohort.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Additional information
A full list of members and affiliations appears in Supplementary Note 1.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–8, Supplementary Tables 1, 2, 4–10, 12,13 and Supplementary Note (PDF 8882 kb)
Supplementary Table 3
Association summary statistics at 38 previously known loci where lead variants reached exome-wide significance (XLSX 20 kb)
Supplementary Table 11
The association of 363 independent variants in the known loci identified by GLGC exome chip study in the East Asian samples (XLSX 62 kb)
Supplementary Table 14
Studies contributing to East Asian meta-analysis (XLSX 12 kb)
Supplementary Table 15
Descriptive statistics for lipid levels across GLGC exome contributing studies (XLSX 19 kb)
Supplementary Table 16
Contributing studies genotyping and analysis information (XLSX 11 kb)
Rights and permissions
About this article
Cite this article
Lu, X., Peloso, G., Liu, D. et al. Exome chip meta-analysis identifies novel loci and East Asian–specific coding variants that contribute to lipid levels and coronary artery disease. Nat Genet 49, 1722–1730 (2017). https://doi.org/10.1038/ng.3978
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.3978
This article is cited by
-
A prediction model for the impact of environmental and genetic factors on cardiovascular events: development in a salt substitutes population
Journal of Translational Medicine (2023)
-
A common East-Asian ALDH2 mutation causes metabolic disorders and the therapeutic effect of ALDH2 activators
Nature Communications (2023)
-
The role of aldehyde dehydrogenase 2 in cardiovascular disease
Nature Reviews Cardiology (2023)
-
Integrating polygenic and clinical risks to improve stroke risk stratification in prospective Chinese cohorts
Science China Life Sciences (2023)
-
Chromogranin A and its derived peptides: potential regulators of cholesterol homeostasis
Cellular and Molecular Life Sciences (2023)